Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Calcitec was a French medical technology company specializing in the development and manufacture of synthetic bone substitutes and biomaterials. The company was a pioneer in the production of high-purity hydroxyapatite (HA) and other calcium phosphate-based materials used for bone grafting in orthopedic and dental applications. Its products were designed to provide a scaffold for new bone growth, offering an alternative to autografts and allografts. Calcitec's technology was highly regarded for its biocompatibility and osteoconductive properties. In 1997, the company was acquired by Wright Medical Technology, which utilized Calcitec's expertise to expand its portfolio of biologic products. Today, the legacy of Calcitec's technology resides within Stryker, following its acquisition of Wright Medical.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Calcitec.